News | Treatment Planning | March 08, 2019

Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case

Collaboration marks first case in U.S. combining the two technologies

Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case

March 8, 2019 — Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation and Accuray's TomoTherapy Treatment Delivery System. This is the first-ever treatment in the U.S. using the two technologies in combination.

Anderson Regional Cancer Center first began using RayStation in 2013 with its conventional linear accelerators, which provided significant benefits for workflow and patient treatments. The center then added the TomoTherapy System for radiation treatment. Anderson has worked closely with RaySearch and Accuray to join the technologies and is now using RayStation for all radiation treatment planning, which is providing substantial gains in efficiency. Additionally, the high-precision treatment delivery provided by the TomoTherapy System will help ensure the best possible radiation treatments for patients.

The first treatment combining RayStation and TomoTherapy System at Anderson Regional Cancer Center was successfully administered to treat a prostate cancer patient. Moving forward, the center plans to use this combination of TPS and radiation treatment delivery system to also treat cancers of the breast, lung, and head and neck.

Scott Anderson, M.D., radiation oncologist and medical director at Anderson Regional Cancer Center, said: "We have watched these progressive companies develop through the years, and we are all very excited to be at this juncture. Integrating RayStation planning for multiple accelerator platforms enables us to fully embrace the TomoTherapy System's advantages. The future of our patients certainly looks brighter with the ability to unify these developments."

Paul King, chief medical physicist at Anderson Regional Cancer Center, said: "This clinical launch is very significant. It is a big step in an evolving story that has just begun, considering the quality of RayStation's design as it is today, as well as the intensity and direction of its ongoing development."

For more information: www.raysearchlabs.com, www.accuray.com

Related Content

High-dose Radiation Effective for Men Whose Prostate Cancer Has Spread
News | Prostate Cancer | September 23, 2019
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the...
First Patients Treated With Machine Learning-generated Plans from RayStation 8B
News | Treatment Planning | September 23, 2019
The first-ever patient radiation therapy treatments generated with machine learning in the RayStation treatment...
An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

Feature | ASTRO | September 23, 2019
August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced th
Videos | Radiation Oncology | September 20, 2019
Anne Hubbard, MBA, director of health policy for ASTRO, explains the details and purpose of the proposed Radiation On
Videos | Radiation Therapy | September 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with...
Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019
News | Patient Positioning Radiation Therapy | September 20, 2019
Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual...
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
News | Proton Therapy | September 20, 2019
Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360...
Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), explains the details of the proposed radiation oncology alternative payment model (APM), and issues ASTRO has raised with the model, at the 2019 ASTRO annual meeting in Chicago.

News | Radiation Oncology | September 18, 2019
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the...
Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...